{"id":5430,"date":"2024-03-18T16:18:00","date_gmt":"2024-03-18T15:18:00","guid":{"rendered":"https:\/\/saccosystem.com\/?post_type=news&p=5430"},"modified":"2024-12-11T16:34:21","modified_gmt":"2024-12-11T15:34:21","slug":"list-biotherapeutics-and-sacco-system-announce-lead-share-agreement","status":"publish","type":"news","link":"https:\/\/saccosystem.com\/de\/news\/list-biotherapeutics-and-sacco-system-announce-lead-share-agreement\/","title":{"rendered":"List Biotherapeutics and Sacco System Announce Lead Share Agreement"},"content":{"rendered":"\n
\n
\n

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 \u2013 List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce and mutually recommend each other\u2019s microbial development and manufacturing services to prospective customers if one party discovers a project that is better suited to the other party\u2019s capability or capacity. No intellectual property will be exchanged between the companies.

Sacco specializes in the development and production of probiotics, postbiotics and live bacterial therapeutics for the agri-food, food supplements and pharmaceutical industry.

List Bio and its sister company, List Labs, specialize in the development and production of innovative bacterial based therapeutic products, including GMP Manufacturing of live biotherapeutic products (LBPs), and other types of microbiome-based therapeutics. Expertise includes vast experience in purification of bacterially derived proteins and toxins for the pharmaceutical and biotechnology industries, with a catalog of over 100 reagent grade products used in medical research and vaccine development throughout the world. List Labs boasts over 45 years of experience with bacterial derived products and a facility in Campbell, Calif. for manufacturing of early phase clinical trial material.    <\/p>\n\n\n\n

\u201cThis lead share agreement will help us meet the diverse global needs of microbiome therapeutics development and commercialization in a thriving market, where over 100 companies are actively developing more than 240 microbiome modulator candidates,\u201d said List Bio President and CEO Jonathan Jo<\/strong>. \u201cWe are delighted to expand List Labs and List Bio\u2019s integrated cGMP pharma grade anaerobic and spore forming microbe production capabilities to biotherapeutic developers in Europe and the Asia Pacific region through Sacco\u2019s strong client base.\u201d

Sacco Managing Director John Goebel<\/strong> said, \u201cSacco looks forward to offering our large-scale fermentation capabilities to any List Bio or List Labs biotherapeutics clients who wish to manufacture probiotics and LBPs in large volume. We are confident that this will be the first of many future strategic alliances as the microbiome market continues to grow.\u201d <\/p>\n\n\n\n

About Sacco System<\/h2>\n\n\n\n

Sacco System is an international company with a deep expertise in research and production of bacteria for food, plant, animal nutrition, nutraceutical, and pharmaceutical industries, built on more than 150 years of tradition, know-how and innovation.<\/p>\n\n\n\n

Heritage in Lactic Acid Bacteria (LAB) began in 1948, when Dr Leo Vesely founded Centro Sperimentale del Latte (CSL, integral part of Sacco System group) to improve maternal health and children\u2019s nutrition.
Operating today in over 110 countries worldwide, Sacco System provides its expertise on probiotic research, development and manufacturing for the human wellbeing. A know-how not limited to LAB but to the entire microbiome landscape.<\/p>\n\n\n\n

At Sacco System, expertise lies in tailoring solutions to meet diverse industry needs. Serving as a reliable partner, comprehensive support is available with a range of services and solutions, including:
\u2022 Process development & fermentation
\u2022 Product formulation
\u2022 In vitro and in vivo trials
\u2022 Market Expansion
\u2022 Regulatory Support
\u2022 Molecular biology & laboratory analysis<\/p>\n\n\n\n

With its 8 facilities, Sacco System partners with companies in the development, process validation, and finished product manufacturing of probiotics, postbiotics, Next-Generation bacteria (strict anaerobes) and biotherapeutics (LBPs).<\/p>\n\n\n\n

max.rossetto@saccosystem.com
Max Rossetto<\/strong>
Global Business  Development Director, Microbial Therapeutics Sacco System<\/p>\n\n\n\n

About List Bio<\/strong><\/h2>\n\n\n\n

List Biotherapeutics, Inc. is dedicated to meeting the needs of companies seeking to rapidly and cost-effectively advance live biotherapeutic products (LBPs) through Phase 3 clinical development and commercial manufacturing. Incorporated in October 2021 under its parent company, South Korea-based Genome & Company (KOSDAQ: 314130), List Bio complements the clinical Phase 1 and 2 production capabilities of its sister company, List Labs. Together the companies provide an end-to-end manufacturing solution for LBPs. List Bio plans to expand with additional modalities and custom manufacturing at its site in Fishers, IN, with the buildout capacity to become a top 3 global microbiome CDMO. The company\u2019s long-term plan includes a world-class 130,000 sq ft CMO facility that is cGMP compliant with FDA and EMA standards, and that is designed to meet the demands of large-scale manufacturing of aerobic and anaerobic bacterial strains.<\/p>\n\n\n\n

For more information, please visit our website http:\/\/www.listlabs.com or contact Gary Henderson, Director of Business Development at ghenderson@listlabs.com.<\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n

\n
\n
\n <\/div>\n <\/div><\/div><\/div>\n<\/div><\/div>\n\n\n
\n
\n
\n

\n Ultime news <\/h2>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n 19 M\u00e4rz 2026 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505\u00ae receives GRAS status <\/div>\n
\n <\/div>\n
\n

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505\u00ae HI.<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 24 Januar 2026 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n SYNBIO\u00ae: Sacco System’s probiotic support for healthy ageing <\/div>\n
\n <\/div>\n
\n

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 20 November 2025 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME\u00ae model <\/div>\n
\n <\/div>\n
\n

\u201cSurvivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME\u00ae model\u201d is the title of the study that has been<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 07 Februar 2025 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health <\/div>\n
\n <\/div>\n
\n

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 08 Januar 2025 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Sacco System Australia\u2019s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ <\/div>\n
\n <\/div>\n
\n

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 25 November 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Our 2023 sustainability report is online! <\/div>\n
\n <\/div>\n
\n

Our commitment to sustainability: a review of an evolving journey We are proud to present the fifth edition of our Sustainability Report, an opportunity to reflect on the milestones achieved<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 16 April 2024 <\/div>\n
\n News <\/div>\n <\/div>\n
\n
\n Sacco System is pleased to announce the grand opening of its development site in Australia. <\/div>\n
\n <\/div>\n
\n

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 26 M\u00e4rz 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Sacco System companies have been awarded as Sustainability champions by Ecovadis <\/div>\n
\n <\/div>\n
\n

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 18 M\u00e4rz 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n List Biotherapeutics and Sacco System Announce Lead Share Agreement <\/div>\n
\n <\/div>\n
\n

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 \u2013 List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 26 Februar 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n CSL FRANCE becomes SACCO SYSTEM FRANCE <\/div>\n
\n <\/div>\n
\n

Sacco System is the international biotechnological company dedicated to the food, nutraceutical, and pharmaceutical industries, based on tradition, expertise, research, and innovation which sells and distributes its ingredients in more<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 21 Februar 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Sacco System Supports Action4Diabetes‘ mission <\/div>\n
\n <\/div>\n
\n

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission\u2014a UK-based charity committed to ensuring free access to crucial medical supplies,<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n 19 Februar 2024 <\/div>\n
\n <\/div>\n <\/div>\n
\n
\n Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT <\/div>\n
\n <\/div>\n
\n

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration<\/p>\n <\/div>\n <\/div>\n

\n
\n \n Leggi Articolo <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 \u2013 List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce<\/p>\n","protected":false},"featured_media":3828,"template":"","meta":{"_acf_changed":false},"category_news":[],"tag_news":[],"class_list":["post-5430","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/saccosystem.com\/de\/wp-json\/wp\/v2\/news\/5430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saccosystem.com\/de\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/saccosystem.com\/de\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saccosystem.com\/de\/wp-json\/wp\/v2\/media\/3828"}],"wp:attachment":[{"href":"https:\/\/saccosystem.com\/de\/wp-json\/wp\/v2\/media?parent=5430"}],"wp:term":[{"taxonomy":"category_news","embeddable":true,"href":"https:\/\/saccosystem.com\/de\/wp-json\/wp\/v2\/category_news?post=5430"},{"taxonomy":"tag_news","embeddable":true,"href":"https:\/\/saccosystem.com\/de\/wp-json\/wp\/v2\/tag_news?post=5430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}